The current study indicated that by inhibiting the combination of PD1 and PD-L1, T cell function was restored, abnormal activation of PI3K/mTOR and MAPK pathways was suppressed, CRC cell proliferation and migration was reduced, and apoptosis was promoted. This evidence concerns the gene MTOR and colorectal carcinoma.